Elutia logo

Elutia

ELUT | NASDAQ
Chart Builder DCF Calculator
$0.82
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
$0.00 (+0.35%)
After-hours: Nov 16, 2026, 4:10 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
60.5
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #132/1021 (Top 13%)

Key Statistics

Market Data

Market Cap $36.45M
1D Range
0.80 0.84
52W Range
0.51 1.22

Valuation (TTM)

PE 0.75
PB 2.38
EV/EBITDA -0.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $10.00
Loading financial charts...

Profile

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’...

Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Oct 7, 2020
Website elutia.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.04
Beat +73.33%
REV
$1.14M
Beat +13.70%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.